Infections in systemic connective tissue diseases: systemic lupus erythematosus, scleroderma, and polymyositis/dermatomyositis (Q35084903)

6 August 2017

1 reference

title

Infections in systemic connective tissue diseases: systemic lupus erythematosus, scleroderma, and polymyositis/dermatomyositis. (English)

1 reference

systemic lupus erythematosus

6 August 2017

0 references

0 references

1 reference

1 reference

Marcela Juárez

1

1 reference

PubMed ID

12635506

6 August 2017

Richard Misischia

series ordinal

2

1 reference

PubMed ID

12635506

6 August 2017

Graciela S Alarcón

series ordinal

3

1 reference

6 August 2017

1 February 2003

1 reference

Rheumatic Diseases Clinics of North America

6 August 2017

1 reference

6 August 2017

29

1 reference

6 August 2017

1

1 reference

6 August 2017

163-184

1 reference

Systemic lupus erythematosus in three ethnic groups. VII [correction of VIII]. Predictors of early mortality in the LUMINA cohort. LUMINA Study Group

6 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900100-X

7 January 2021

Morbidity and mortality in systemic lupus erythematosus during a 5-year period. A multicenter prospective study of 1,000 patients. European Working Party on Systemic Lupus Erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900100-X

7 January 2021

Infectious diseases in systemic lupus erythematosus: risk factors, management and prophylaxis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900100-X

7 January 2021

The nature and outcome of infection in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900100-X

7 January 2021

Mortality and causes of death in a Swedish series of systemic sclerosis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900100-X

7 January 2021

Risk factors and prognostic influence of infection in a single cohort of 87 adults with systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900100-X

7 January 2021

Risk factors for infection in Malaysian patients with systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900100-X

7 January 2021

Respiratory complications in mixed connective tissue disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900100-X

7 January 2021

Early damage as measured by the SLICC/ACR damage index is a predictor of mortality in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900100-X

7 January 2021

Causes of death in systemic lupus erythematosus. Long-term followup of an inception cohort

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900100-X

7 January 2021

Infections in outpatients with systemic lupus erythematosus: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900100-X

7 January 2021

Fatal infections in systemic lupus erythematosus: the role of opportunistic organisms.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900100-X

7 January 2021

Causes of death in patients with systemic lupus erythematosus in São Paulo, Brazil: a study of 113 autopsies

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900100-X

7 January 2021

Computer analysis of factors influencing frequency of infection in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900100-X

7 January 2021

Complement deficiency states and infection: epidemiology, pathogenesis and consequences of neisserial and other infections in an immune deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900100-X

7 January 2021

Increased risk of neisserial infections in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900100-X

7 January 2021

Mannose-binding lectin polymorphisms and susceptibility to infection in systemic lupus erythematosus.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900100-X

7 January 2021

Association of mannose-binding lectin gene variation with disease severity and infections in a population-based cohort of systemic lupus erythematosus patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900100-X

7 January 2021

Infections in systemic lupus erythematosus and rheumatoid arthritis.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900100-X

7 January 2021

Infection in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900100-X

7 January 2021

Decreased expression of the C3b/C4b receptor (CR1) and the C3d receptor (CR2) on B lymphocytes and of CR1 on neutrophils of patients with systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900100-X

7 January 2021

Defective phagocytosis, decreased tumour necrosis factor-alpha production, and lymphocyte hyporesponsiveness predispose patients with systemic lupus erythematosus to infections

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900100-X

7 January 2021

T helper cell dysfunction in systemic lupus erythematosus (SLE): relation to disease activity

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900100-X

7 January 2021

Glucocorticoid therapy for immune-mediated diseases: basic and clinical correlates

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900100-X

7 January 2021

Infections in nonleukopenic compromised hosts (diabetes mellitus, SLE, steroids, and asplenia) in critical care

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900100-X

7 January 2021

Immunopathogenesis and spectrum of infections in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900100-X

7 January 2021

Immunosuppression by glucocorticoids: inhibition of NF-kappa B activity through induction of I kappa B synthesis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900100-X

7 January 2021

Update on cyclophosphamide for systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900100-X

7 January 2021

Risk factors for serious infection during treatment with cyclophosphamide and high-dose corticosteroids for systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900100-X

7 January 2021

Severe infections in plasmapheresis-treated systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900100-X

7 January 2021

Treatment of severe systemic lupus erythematosus with high-dose chemotherapy and haemopoietic stem-cell transplantation: a phase I study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900100-X

7 January 2021

Mortality of Jamaican patients with systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900100-X

7 January 2021

A prospective study of survival and prognostic indicators of systemic lupus erythematosus in a southern Chinese population

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900100-X

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900100-X

7 January 2021

Mortality and causes of death of 513 Danish patients with systemic lupus erythematosus.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900100-X

7 January 2021

A multicenter study of outcome in systemic lupus erythematosus. II. Causes of death

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900100-X

7 January 2021

Salmonella bacteremia in systemic lupus erythematosus. Eight-year experience at a municipal hospital

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900100-X

7 January 2021

Non-thyphoidal salmonellosis in patients with systemic lupus erythematosus. A study of fifty patients and a review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900100-X

7 January 2021

Nocardiosis in systemic lupus erythematosus.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900100-X

7 January 2021

Tuberculosis among Filipino patients with systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900100-X

7 January 2021

Mycobacterium intracellulare infection of the shoulder and spine in a patient with steroid-treated systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900100-X

7 January 2021

Association of human immunodeficiency virus infection and autoimmune phenomena

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900100-X

7 January 2021

Human parvovirus B19 infection in patients with systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900100-X

7 January 2021

Pneumocystis carinii pneumonia in patients with systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900100-X

7 January 2021

Aspergillosis in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900100-X

7 January 2021

SLE with death from acute massive pulmonary hemorrhage caused by disseminated strongyloidiasis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900100-X

7 January 2021

Visceral Leishmaniasis mimicking a flare of systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900100-X

7 January 2021

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900100-X

1 reference

7 January 2021

Scleroderma and related conditions

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900100-X

7 January 2021

Pharyngo-oesophageal dysphagia in systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900100-X

7 January 2021

Clinical images: Progressive calcifications and draining lesions following staphylococcal infection in a patient with limited scleroderma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900100-X

7 January 2021

Phase I/II trial of autologous stem cell transplantation in systemic sclerosis: procedure related mortality and impact on skin disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900100-X

7 January 2021

Recombinant human relaxin in the treatment of scleroderma. A randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900100-X

7 January 2021

Systemic sclerosis: demographic, clinical, and serologic features and survival in 1,012 Italian patients

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900100-X

7 January 2021

Predicting mortality in systemic sclerosis: analysis of a cohort of 309 French Canadian patients with emphasis on features at diagnosis as predictive factors for survival

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900100-X

7 January 2021

Epidemiological analysis of prognosis of 496 Japanese patients with progressive systemic sclerosis (SSc). Scleroderma Research Committee Japan

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900100-X

7 January 2021

Pyomyositis in a patient with progressive systemic sclerosis. Case report and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900100-X

7 January 2021

Nocardial endophthalmitis: report of two cases studied histopathologically

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900100-X

7 January 2021

Autoimmunity and vascular involvement in systemic sclerosis (SSc).

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900100-X

7 January 2021

Pneumocystis carinii pneumonia in patients with connective tissue diseases: the role of hospital experience in diagnosis and mortality

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900100-X

7 January 2021

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900100-X

1 reference

7 January 2021

The lung in polymyositis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900100-X

7 January 2021

Juvenile dermatomyositis--acute recidivism or sepsis?

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900100-X

7 January 2021

Juvenile dermatomyositis presenting with rash alone

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900100-X

7 January 2021

Staphylococcal infections in childhood dermatomyositis--association with the development of calcinosis, raised IgE concentrations and granulocyte chemotactic defect

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900100-X

7 January 2021

Does methotrexate increase the risk of infection or malignancy?

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900100-X

7 January 2021

[Respiratory failure in polymyositis and dermatomyositis: differential diagnosis between pulmonary infection and interstitial pneumonitis]

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900100-X

7 January 2021

Streptococcal myositis as a complication of juvenile dermatomyositis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900100-X

7 January 2021

[Generalized Mycobacterium avium-intracellulare infection due to immunosuppressive therapy of paraneoplastic dermatomyositis]

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900100-X

7 January 2021

Herpes zoster in patients with polymyositis and dermatomyositis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900100-X

7 January 2021

A causal role for parvovirus B19 infection in adult dermatomyositis and other autoimmune syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900100-X

7 January 2021

Juvenile dermatomyositis in a child infected with human parvovirus B19

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900100-X

7 January 2021

Mucocutaneous candidiasis in patients with skin diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900100-X

7 January 2021

Disseminated histoplasmosis presenting as myositis and fasciitis in a patient with dermatomyositis.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900100-X

7 January 2021

A multicentre study of 513 Danish patients with systemic lupus erythematosus. I. Disease manifestations and analyses of clinical subsets.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900100-X

7 January 2021

Long-term survival in systemic lupus erythematosus. Patient characteristics associated with poorer outcomes

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900100-X

7 January 2021

Musculoskeletal complications of systemic lupus erythematosus in the Hopkins Lupus Cohort: an update

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900100-X

7 January 2021

10.1016/S0889-857X(02)00100-X

Identifiers

DOI

1 reference

6 August 2017

1 reference

PubMed ID

12635506